Can donor t cells beat a tough virus after transplant? new trial aims to find out.
NCT ID NCT03378102
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether infusing virus-fighting T cells from a donor can help stem cell transplant patients overcome a stubborn adenovirus infection. About 20 participants will receive the experimental cell therapy, and researchers will monitor side effects and whether the virus clears. The goal is to see if this approach is safe and feasible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Life-Saving transplant leave hidden scars on a Child's mind?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Could a simple drug infusion stop a dangerous virus after stem cell transplants?
- Study to reveal if younger donors boost transplant success
- Ancient heat therapy tested for Life-Threatening transplant complication
- Food bags for transplant patients: a recipe for better recovery?